Case Study: How an Entire Industry adopts Digital Enterprise Identity

In order to watch this video, you have to log in or create an account, if you don't have one yet.
This video is only available to registered participants of the event.

Back in November 2013 the U.S. congress enacted the Drug Supply Chain Security Act (DSCSA). Part of the regulation is that actors within the U.S. pharmaceutical industry must verify the U.S. state license, which is issued by the U.S. Drug Enforcement Administration (DEA), status (and thus the authenticity) of every trading partner within their supply chain. And this does not stop just by direct trading partners a pharmaceutical supply chain actor might have, the regulation states, that also indirect trading partner’s U.S. state license status must be proofed.

Dr. Carsten Stöcker, Co-founder and CEO, Spherity

Language: English • Duration: 21:19 • Resolution: 1280x720

Learn more about this hybrid event

Stay Connected

KuppingerCole on social media

How can we help you

Send an inquiry

Call Us +49 211 2370770

Mo – Fr 8:00 – 17:00